IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
An Economic Evaluation of Pharmacist’ Intervention to Improve Blood Pressure Control: A Systematic Review

Author: YOPI RIKMASARI, SUSI ARI KRISTINA, TRI MURTI ANDAYANI, DWI ENDARTI
Abstract: Background: Suboptimal blood pressure control is a risk factor associated with cardiovascular disease. An adequate number and dose of prescribed blood pressure medications and adherence with therapy are two main factors that affect the patient's blood pressure control. Pharmacist intervention is expected to solve these problems. The purpose of this review is to summarize the type of interventions involving a pharmacist to improve blood pressure control in hypertension patients and the impact on the clinical, economic, or humanistic outcome. Methods: We conducted a systematic search using Pubmed, Scopus, and ScienceDirect databases published from 2010 until 2020. The terms used in the search were hypertension and pharmacist and intervention and cost of economic evaluation. The articles were collected according to the inclusion criteria and the quality of the evaluation study using the 10-item Drummond Checklist then the results were extracted and analyzed systematically. Results: A total of four articles were carried out for analysis. The same type of intervention was found in the physician-pharmacist collaboration and we found that the ICER value to reduce 1 mmHg of systolic in three articles was $ 33.27, $ 22.21 and $ 36.25 per 1 mmHg SBP. For diastolic blood pressure, there were ICER value of $ 69.98, $ 66.0 and $ 94.32 per 1 mmHg DBP and$ 53.50/1 QALY in one study. Conclusion: It can be concluded that pharmacist intervention in the form of physician-pharmacist collaboration is cost-effective and provides benefits to blood pressure control in hypertensive patients. Even so, the articles discussed are still very few and pharmacoeconomics studies have not used modeling. In the future, it is necessary to explore further about the form of doctor-pharmacist collaboration intervention in hypertensive patients at a cost that is acceptable to interested parties and can be carried out widely in various health services.
Keyword: Hypertension, cost-effectiveness, physician-pharmacist collaboration
DOI: https://doi.org/10.31838/ijpr/2021.13.02.184
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free